Log In
BCIQ
Print this Print this
 

Lialda, Mesavancol, Mezavant, Mezavant XL, mesalamine (MMX Mesalazine) (GED 0001, MD-0901, SPD476)

Also known as: formerly Mesavance

  Manage Alerts
Collapse Summary General Information
Company Nogra Pharma Ltd.
Description5-aminosalicylate (5-ASA) mesalamine formulated using Multi-Matrix system (MMX) technology
Molecular Target Cyclooxygenases (COX)
Mechanism of ActionCyclooxygenase (COX) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/18/2009

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today